國立虎尾科技大學 |

Atlas of Response to Immunotherapy

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Atlas of Response to Immunotherapy/ edited by Egesta Lopci, Stefano Fanti.
其他作者:	Lopci, Egesta.
面頁冊數:	VIII, 127 p. 111 illus., 100 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Nuclear medicine. -
電子資源:	https://doi.org/10.1007/978-3-030-31113-1
ISBN:	9783030311131

Atlas of Response to Immunotherapy
Atlas of Response to Immunotherapy[electronic resource] /edited by Egesta Lopci, Stefano Fanti. - 1st ed. 2020. - VIII, 127 p. 111 illus., 100 illus. in color.online resource.

PART I BRIEF INTRODUCTION: Immunotherapy in oncology -- Evolution of response criteria -- Part II DIESEASE-ORIENTED APPLICATIONS: CNS -- Thorax -- Melanoma -- Gastrointestinal -- Genitourinary -- Hematologic -- Other tumor types -- PART III PITFALLS AND IMMUNE-RELATED ADVERSE EVENTS (IrAEs) PART IV IMMUNO-PET.

This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment. A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases. To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy. The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario. The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.

ISBN: 9783030311131

Standard No.: 10.1007/978-3-030-31113-1doiSubjects--Topical Terms:

673902
Nuclear medicine.

LC Class. No.: R895-920

Dewey Class. No.: 616.07548

Atlas of Response to Immunotherapy
LDR:02907nam a22003975i 4500 001 1025280
003 DE-He213
005 20200706055535.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030311131 $9 978-3-030-31113-1
024 7 $a 10.1007/978-3-030-31113-1 $2 doi
035 $a 978-3-030-31113-1
050 4 $a R895-920
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.07548 $2 23
245 1 0 $a Atlas of Response to Immunotherapy $h [electronic resource] / $c edited by Egesta Lopci, Stefano Fanti.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a VIII, 127 p. 111 illus., 100 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a PART I BRIEF INTRODUCTION: Immunotherapy in oncology -- Evolution of response criteria -- Part II DIESEASE-ORIENTED APPLICATIONS: CNS -- Thorax -- Melanoma -- Gastrointestinal -- Genitourinary -- Hematologic -- Other tumor types -- PART III PITFALLS AND IMMUNE-RELATED ADVERSE EVENTS (IrAEs) PART IV IMMUNO-PET.
520 $a This atlas is a concise but comprehensive guide to the diverse patterns of response to immunotherapy as observed on Positron Emission Tomography/Computed Tomography (PET/CT) and other conventional imaging modalities, including CT and Magnetic Resonance Imaging (MRI). The purpose for this publication is to fill the gap between the growing clinical relevance and utilization of immunotherapy in medical oncology, mainly based on checkpoint inhibitors, and the need for experienced imagers with reliable tools assessing response to treatment. A series of disease-oriented chapters will present the imaging findings during immunotherapy in the major oncological settings, with helpful comparison of functional (PET/CT) and morphological (CT/MRI) patterns of response in individual cases. To complete the atlas, a dedicated chapter will focus on major pitfalls and immune-related adverse events (irAEs) affecting image interpretation during the course of immunotherapy. The concluding chapter will lastly examine the available data and potential developments of immuno-PET, which is considered as the novel frontier of research in this oncological scenario. The atlas will be of high value for radiologists and nuclear medicine specialists at all levels of experience.
650 0 $a Nuclear medicine. $3 673902
650 0 $a Oncology . $3 1253469
650 0 $a Immunology. $3 592892
650 0 $a Radiology. $3 673943
650 1 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Oncology. $3 593951
650 2 4 $a Diagnostic Radiology. $3 593950
700 1 $a Lopci, Egesta. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1272581
700 1 $a Fanti, Stefano. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 796628
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030311124
776 0 8 $i Printed edition: $z 9783030311148
776 0 8 $i Printed edition: $z 9783030311155
856 4 0 $u https://doi.org/10.1007/978-3-030-31113-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)